Comparison

SOX7 Blocking Peptide (C-term)

Manufacturer Abcepta
Category
Type Peptides
Specific against other
Format Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Amount 500 ug
Item no. ABC-BP21030c
eClass 6.1 34160400
eClass 9.0 32160409
Available
Primary Accession
Q9BT81
Bio Background
Binds to and activates the CDH5 promoter, hence plays a role in the transcriptional regulation of genes expressed in the hemogenic endothelium and blocks further differentiation into blood precursors (By similarity). May be required for the survival of both hematopoietic and endothelial precursors during specification (By similarity). Competes with GATA4 for binding and activation of the FGF3 promoter (By similarity). Represses Wnt/beta-catenin-stimulated transcription, probably by targeting CTNNB1 to proteasomal degradation. Binds the DNA sequence 5'- AACAAT-3'.
Bio References
Takash W., et al.Nucleic Acids Res. 29:4274-4283(2001).
Ota T., et al.Nat. Genet. 36:40-45(2004).
Kalnine N., et al.Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
Guo L., et al.Mol. Cancer Res. 6:1421-1430(2008).
Gene ID
83595
Gene Name
SOX7
Subtitle
Synthetic peptide
Other Accession
P40646
Target/Specificity
The synthetic peptide sequence is selected from aa 319-333 of HUMAN SOX7

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Delivery expected until 6/6/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close